Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: firstname.lastname@example.org
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo! News
Get the latest health news headlines from Yahoo! News. Find breaking health news, including analysis and opinion on
top health stories.
Cancer Society hits 100 as US cancer rate falls
22 May 2013 at 12:12am
NEW YORK (AP) ? The American Cancer Society ? one of the nation's best known and influential health advocacy groups ? is 100 years old this week.
Portland, Ore., rejecting water fluoridation
21 May 2013 at 11:58pm
PORTLAND, Ore. (AP) ? The mayor of Portland, Ore., has conceded defeat in an effort to add fluoride to the city's drinking water.
Report: NPS hantavirus response followed policy
20 May 2013 at 9:11pm
YOSEMITE NATIONAL PARK, Calif. (AP) ? Federal investigators probing the hantavirus outbreak blamed for three deaths at Yosemite National Park recommended on Monday that design changes to tent cabins and other privately run lodging first be reviewed by National Park Service officials.
Los Angeles voters OK move to curtail medical marijuana outlets
22 May 2013 at 3:54am
By Alex Dobuzinskis LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale of pot for health reasons, election returns early on Wednesday showed. The proposal appeared headed for passage. Returns showed 63 percent of voters supporting it compared with 37 percent opposed, after tabulation of more than 40 percent of ballots cast at polling stations on Tuesday, and all of the mail-in ballots received as of last Friday. ...
Immune system cancer drugs tipped to be a $35 billion market
22 May 2013 at 2:48am
By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank Citigroup highlights the growing excitement surrounding so-called immunotherapy after positive results from clinical trials conducted by companies such as Bristol-Myers Squibb and Roche Holding. ...
Merck signs $5 billion share buyback agreement with Goldman Sachs
21 May 2013 at 11:07pm
(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff competition from makers of less-costly generics. Under the accelerated share repurchase agreement (ASR), Merck has agreed to repurchase about 99.5 million shares from Goldman Sachs based on current market prices. ...
Couple Pleads for Son's Stolen Ashes
21 May 2013 at 9:42pm
The silver memory box was the couple's only memento of their stillborn son.
How To Enjoy Your Decision
21 May 2013 at 9:00pm
When facing a lot of choice it is best to decide on one option and then physically shut off all others. Christie Nicholson reports
Cheruiyot expecting first child, aims to return in 2014
21 May 2013 at 8:56pm
(Reuters) - Vivian Cheruiyot is not defending her world 5,000 and 10,000 meters gold medals in Moscow in August because she is expecting her first child, the Kenyan said in a statement. The 29-year-old, who won both races at the 2011 world athletics championships in Daegu, South Korea, took silver and bronze in the 5,000 and 10,000 at last year's London Olympics. In a statement released by her agent Ricky Simms on Wednesday, Cheruiyot said she would resume her career next year. She had first revealed her decision not to compete in Moscow on Tuesday but gave no reason for her absence. ...
Athletics-Cheruiyot expecting first child, aims to return in 2014
21 May 2013 at 8:41pm
May 22 (Reuters) - Vivian Cheruiyot is not defending her world 5,000 and 10,000 metres gold medals in Moscow in August because she is expecting her first child, the Kenyan said in a statement. The 29-year-old, who won both races at the 2011 world athletics championships in Daegu, South Korea, took silver and bronze in the 5,000 and 10,000 at last year's London Olympics. In a statement released by her agent Ricky Simms on Wednesday, Cheruiyot said she would resume her career next year. She had first revealed her decision not to compete in Moscow on Tuesday but gave no reason for her absence. ...
Portland, Ore., voting on water fluoridation
21 May 2013 at 7:24pm
PORTLAND, Ore. (AP) ? Oral health and politics collided Tuesday as Portlanders ? proudly nonconformist and environmentally minded ? decided whether their city remains the largest in the U.S. without public fluoridation.
Healthcare workers strike at five California public hospitals
21 May 2013 at 6:24pm
By Ronnie Cohen SAN FRANCISCO (Reuters) - Thousands of healthcare workers walked off the job at the University of California's five medical centers on Tuesday, delaying emergency care, surgeries, diagnostic procedures and other medical treatment throughout the state. The union representing nearly 13,000 vocational nurses, respiratory therapists and radiology technicians said it called the two-day strike to draw attention to staff shortages they said undermine patient care at the hospitals in San Francisco, Davis, Los Angeles, San Diego and Irvine. ...
Amag investigates anemia drug after report of death in Switzerland
21 May 2013 at 5:43pm
(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity. Amag shares were down about 5 percent at $23.75 in after-market trading on Tuesday. "The batch was only distributed to and sold in Switzerland and the recall is limited to the specific batch and specifically Switzerland," Lexington, Massachusetts-based Amag said in a regulatory filing on Tuesday. (http://r.reuters. ...
Tornado Struck Hospital but Patients, Staff Unharmed
21 May 2013 at 5:07pm
Patients, Staff at Moore Medical Center Uninjured in Tornado
Tornado Warning: Despite Oklahoma Alert, U.S. Weather Forecasting Service Nee...
21 May 2013 at 4:22pm
The atmosphere never gets a moment?s privacy. It can barely stir enough to move a leaf without some piece of high-tech equipment?often many, many pieces?knowing about it. The U.S. alone has up to 30 satellites at any one moment that devote at least part of their time to monitoring global and national weather patterns; 122 Doppler radar systems scattered across the country looking up from the ground; and a web of computers that just got a massive upgrade?increasing their data-crunching capacity 30-fold?to process the information that all that other hardware gathers.